Reuters logo
BRIEF-Innate Pharma dose-escalation data show favorable safety profile
June 15, 2017 / 5:20 AM / 5 months ago

BRIEF-Innate Pharma dose-escalation data show favorable safety profile

June 15 (Reuters) - INNATE PHARMA SA:

* REG-INNATE PHARMA : DOSE-ESCALATION DATA SHOW FAVORABLE SAFETY PROFILE AND PROMISING CLINICAL ACTIVITY FOR IPH4102 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below